Ginkgo Bioworks Holdings Inc. Class A Company Profile
NYSE: DNAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
11.47-0.94 (-7.57%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 11.31 -1.39%
Ginkgo Bioworks at a glance
Ginkgo Bioworks Holdings Inc. Class A (NYSE: DNA) is a Biotechnology: Biological Products (No Diagnostic Substances) company in the Health Care sector. The company's shares have traded publicly since 2021. At a market capitalization of $798.5 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001830214, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
Company information
- Legal name
- Ginkgo Bioworks Holdings Inc. Class A
- Ticker
- NYSE: DNA
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Headquarters
- United States
- IPO year
- 2021
- Market cap
- $798.46M
- SEC CIK
- 0001830214
Companies similar to Ginkgo Bioworks
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| SANASana Biotechnology Inc. | 2.72 | -1.09% | $814.26M | vs DNA |
| CADLCandel Therapeutics Inc. | 9.82 | -0.51% | $751.41M | vs DNA |
| SLBTSL Science Holding Limited | 1.51 | -0.66% | $846.75M | vs DNA |
| ATTOAttovia Therapeutics Inc. | 16.42 | -6.17% | $749.59M | vs DNA |
| SLDBSolid Biosciences Inc. | 6.85 | -1.01% | $734.49M | vs DNA |
| GLUEMonte Rosa Therapeutics Inc. | 10.17 | +3.04% | $867.64M | vs DNA |
| ODTXOdyssey Therapeutics Inc. | 18.08 | -0.28% | $868.90M | vs DNA |
| PRMEPrime Medicine Inc. | 3.90 | +11.43% | $707.37M | vs DNA |